These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 8498753

  • 1. Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats.
    Kirk CA, Feldman EC, Nelson RW.
    Am J Vet Res; 1993 Mar; 54(3):463-7. PubMed ID: 8498753
    [Abstract] [Full Text] [Related]

  • 2. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response.
    Mattheeuws D, Rottiers R, Kaneko JJ, Vermeulen A.
    Am J Vet Res; 1984 Jan; 45(1):98-103. PubMed ID: 6367563
    [Abstract] [Full Text] [Related]

  • 3. Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats.
    Hoenig M, Jordan ET, Ferguson DC, de Vries F.
    Domest Anim Endocrinol; 2010 Feb; 38(2):95-102. PubMed ID: 19781890
    [Abstract] [Full Text] [Related]

  • 4. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [Abstract] [Full Text] [Related]

  • 5. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats.
    Nelson RW, Feldman EC, Ford SL, Roemer OP.
    J Am Vet Med Assoc; 1993 Sep 15; 203(6):821-7. PubMed ID: 8226235
    [Abstract] [Full Text] [Related]

  • 6. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N, Scheen AJ, Dirlewanger M, Lefèbvre PJ, Tappy L.
    Obes Res; 2002 Mar 15; 10(3):129-34. PubMed ID: 11886934
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The diagnosis and treatment of insulin-dependent and non-insulin-dependent diabetes mellitus in the dog and the cat.
    Wallace MS, Kirk CA.
    Probl Vet Med; 1990 Dec 15; 2(4):573-90. PubMed ID: 2134076
    [Abstract] [Full Text] [Related]

  • 10. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
    Lehtihet M, Efendic S, Brismar K.
    Clin Sci (Lond); 2008 Sep 15; 115(5):167-74. PubMed ID: 18208402
    [Abstract] [Full Text] [Related]

  • 11. Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs.
    Verkest KR, Rand JS, Fleeman LM, Morton JM.
    Domest Anim Endocrinol; 2012 Feb 15; 42(2):103-12. PubMed ID: 22130330
    [Abstract] [Full Text] [Related]

  • 12. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 15; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 13. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y, Clodfelder BJ, Shute AA, Irvin T, Vincent JB.
    J Biol Inorg Chem; 2002 Sep 15; 7(7-8):852-62. PubMed ID: 12203022
    [Abstract] [Full Text] [Related]

  • 14. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
    Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A.
    Obes Surg; 2005 Oct 15; 15(9):1258-64. PubMed ID: 16259883
    [Abstract] [Full Text] [Related]

  • 15. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats.
    Hoenig M, Thomaseth K, Brandao J, Waldron M, Ferguson DC.
    Domest Anim Endocrinol; 2006 Nov 15; 31(4):373-89. PubMed ID: 16434162
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children.
    Gupta N, Hoffman RP, Veng-Pedersen P.
    Biopharm Drug Dispos; 2005 Oct 15; 26(7):287-94. PubMed ID: 16013082
    [Abstract] [Full Text] [Related]

  • 17. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
    O'Brien TD, Hayden DW, Johnson KH, Stevens JB.
    Vet Pathol; 1985 May 15; 22(3):250-61. PubMed ID: 3890345
    [Abstract] [Full Text] [Related]

  • 18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep 15; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 19. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM, Nelson RW, Feldman EC, Robertson K, Polonsky KS.
    J Vet Intern Med; 1996 Sep 15; 10(3):116-22. PubMed ID: 8743209
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of plasma islet amyloid polypeptide and serum glucose and insulin concentrations in nondiabetic cats classified by body condition score and in cats with naturally occurring diabetes mellitus.
    Henson MS, Hegstad-Davies RL, Wang Q, Hardy RM, Armstrong PJ, Jordan K, Johnson KH, O'Brien TD.
    Am J Vet Res; 2011 Aug 15; 72(8):1052-8. PubMed ID: 21801062
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.